Publications

1. Balbach ML, Hewlett JR, Wermers RA, Warrington KJ, Tanner SB, Chew EY. Giant cell arteritis associated with intravenous zoledronic acid administration. JBMR Plus. 2024 Apr; 8 (4):ziae015 Epub 2024 Feb 15
   View PubMed
2. Mohan S, Sheehan M, Tebben P, Wermers R. Efficacy of Oral Cinacalcet in Non-PTH Nonmalignant Hypercalcemia from Excess 1,25-Dihydroxyvitamin D. JCEM Case Rep. 2024 Mar; 2 (3):luae022 Epub 2024 Mar 12
   View PubMed
3. Szabo Yamashita T, Mirande M, Huang CT, Kearns A, Fyffe-Freil R, Singh R, Foster T, Thompson G, Lyden M, McKenzie T, Wermers RA, Dy B. Persistence and Recurrence of Hypercalcemia After Parathyroidectomy Over 5 Decades (1965-2010) in a Community-based Cohort. Ann Surg. 2023 Aug 1; 278 (2):e309-e313 Epub 2022 Aug 26
   View PubMed
4. Shaker JL, Wermers RA. The Eucalcemic Patient With Elevated Parathyroid Hormone Levels. J Endocr Soc. 2023 Feb 9; 7 (4):bvad013 Epub 2023 Jan 26
   View PubMed
5. Saha S, Vierkant RA, Johnson GB, Parvinian A, Wermers RA, Foster T, McKenzie T, Dy B, Lyden M. C(11) choline PET/CT succeeds when conventional imaging for primary hyperparathyroidism fails. Surgery. 2023 Jan; 173 (1):117-123 Epub 2022 Oct 11
   View PubMed
6. Minisola S, Arnold A, Belaya Z, Brandi ML, Clarke BL, Hannan FM, Hofbauer LC, Insogna KL, Lacroix A, Liberman U, Palermo A, Pepe J, Rizzoli R, Wermers R, Thakker RV. Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism. J Bone Miner Res. 2022 Nov; 37 (11):2315-2329 Epub 2022 Oct 17
   View PubMed
7. Wang L, Scherer SE, Bielinski SJ, Muzny DM, Jones LA, Black JL 3rd, Moyer AM, Giri J, Sharp RR, Matey ET, Wright JA, Oyen LJ, Nicholson WT, Wiepert M, Sullard T, Curry TB, Rohrer Vitek CR, McAllister TM, St Sauver JL, Caraballo PJ, Lazaridis KN, Venner E, Qin X, Hu J, Kovar CL, Korchina V, Walker K, Doddapaneni H, Wu TJ, Raj R, Denson S, Liu W, Chandanavelli G, Zhang L, Wang Q, Kalra D, Karow MB, Harris KJ, Sicotte H, Peterson SE, Barthel AE, Moore BE, Skierka JM, Kluge ML, Kotzer KE, Kloke K, Vander Pol JM, Marker H, Sutton JA, Kekic A, Ebenhoh A, Bierle DM, Schuh MJ, Grilli C, Erickson S, Umbreit A, Ward L, Crosby S, Nelson EA, Levey S, Elliott M, Peters SG, Pereira N, Frye M, Shamoun F, Goetz MP, Kullo IJ, Wermers R, Anderson JA, Formea CM, El Melik RM, Zeuli JD, Herges JR, Krieger CA, Hoel RW, Taraba JL, St Thomas SR, Absah I, Bernard ME, Fink SR, Gossard A, Grubbs PL, Jacobson TM, Takahashi P, Zehe SC, Buckles S, Bumgardner M, Gallagher C, Fee-Schroeder K, Nicholas NR, Powers ML, Ragab AK, Richardson DM, Stai A, Wilson J, Pacyna JE, Olson JE, Sutton EJ, Beck AT, Horrow C, Kalari KR, Larson NB, Liu H, Wang L, Lopes GS, Borah BJ, Freimuth RR, Zhu Y, Jacobson DJ, Hathcock MA, Armasu SM, McGree ME, Jiang R, Koep TH, Ross JL, Hilden MG, Bosse K, Ramey B, Searcy I, Boerwinkle E, Gibbs RA, Weinshilboum RM. Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. Genet Med. 2022 May; 24 (5):1062-1072 Epub 2022 Mar 21
   View PubMed
8. Wermers RA, Griebeler ML, Thapa P, Hathcock MA, Kearns AE. Survival in primary hyperparathyroidism over five decades (1965-2010) a population-based retrospective study. Bone. 2021 Nov; 152:116099 Epub 2021 July 08
   View PubMed
9. Foster T, Dy B, Rocco R, Mckenzie T, Thompson G, Wermers R, Lyden M. Routine Use of Preoperative Neck Ultrasound in Primary Hyperparathyroidism Identifies Coexisting Thyroid Disease and Improves Parathyroid Localization. Am Surg. 2021 Jan 31; 3134821991991 [Epub ahead of print]
   View PubMed
10. El Kawkgi OM, Li D, Kotwal A, Wermers RA. Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy. Mayo Clin Proc Innov Qual Outcomes. 2020 Dec; 4 (6):821-825 Epub 2020 Nov 03
    View PubMed
11. Shariq OA, Strajina V, Lyden ML, McKenzie TJ, Wermers RA, Thompson GB, Dy BM. Parathyroidectomy improves hypercalciuria in patients with primary hyperparathyroidism. Surgery. 2020 Oct; 168 (4):594-600 Epub 2020 Aug 15
    View PubMed
12. Sheehan MT, Wermers RA, Jatoi A, Loprinzi CL, Onitilo AA. Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy. Med Hypotheses. 2020 Oct; 143:110149 Epub 2020 July 30
    View PubMed
13. Tande AJ, Stevens RW, Wermers RA, Estes LL. Leveraging Existing Strategies of Medication Stewardship to Preserve and Appropriately Use Critical Supplies. Mayo Clin Proc. 2020 Sep; 95 (9S):S29-S32
    View PubMed
14. Berger M, Dy B, McKenzie T, Thompson G, Wermers R, Lyden M. Rates of hypercalcemia and hyperparathyroidism among patients with porcelain gallbladder. Am J Surg. 2020 Jul; 220 (1):127-131 Epub 2019 Oct 07
    View PubMed
15. Kotwal A, Ferrer A, Kumar R, Singh RJ, Murthy V, Schultz-Rogers L, Zimmermann M, Lanpher B, Zimmerman K, Stabach PR, Klee E, Braddock DT, Wermers RA. Clinical and Biochemical Phenotypes in a Family With ENPP1 Mutations. J Bone Miner Res. 2020 Apr; 35 (4):662-670 Epub 2020 Jan 16
    View PubMed
16. Kearns AE, Espiritu RP, Vickers Douglass K, Thapa P, Wermers RA. Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism. Clin Endocrinol (Oxf). 2019 Sep; 91 (3):464-470 Epub 2019 June 25
    View PubMed
17. Kotwal A, Hurtado MD, Sfeir JG, Wermers RA. TRANSIENT OSTEOPOROSIS: CLINICAL SPECTRUM IN ADULTS AND ASSOCIATED RISK FACTORS. Endocr Pract. 2019 Jul; 25 (7):648-656 Epub 2019 Mar 13
    View PubMed
18. Priebe J, Wermers RA, Sems SA, Viozzi CF, Koka S. Relationship of Number of Missing Teeth to Hip Fracture in Elderly Patients: A Cohort Pilot Study. J Prosthodont. 2019 Mar; 28 (3):258-263 Epub 2017 Sept 15
    View PubMed
19. Ebeling PR, Akesson K, Bauer DC, Buchbinder R, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D, Katzman W, Rodriguez A, Wermers R, Wilson HA, Bouxsein ML. The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report. J Bone Miner Res. 2019 Jan; 34 (1):3-21
    View PubMed
20. Thompson KM, Swanson KM, Cox DL, Kirchner RB, Russell JJ, Wermers RA, Storlie CB, Johnson MG, Naessens JM. Implementation of Bar-Code Medication Administration to Reduce Patient Harm. Mayo Clin Proc Innov Qual Outcomes. 2018 Dec; 2 (4):342-351 Epub 2018 Nov 26
    View PubMed
21. Jasim S, Wenger D, Wermers RA. Skeletal Fluorosis Related to Habitual Tea Consumption: Long-term Follow-up after Reduction and Discontinuation of Tea AACE Clinical Case Reports.2018;4:(2):
    
22. Orr LE, McKenzie TJ, Thompson GB, Farley DR, Wermers RA, Lyden ML. Surgery for Primary Hyperparathyroidism with Normal Non-suppressed Parathyroid Hormone can be Both Challenging and Successful. World J Surg. 2018 Feb; 42 (2):409-414
    View PubMed
23. Shah M, Sharma A, Wermers RA, Kennel KA, Kellogg TA, Mundi MS. Hypocalcemia After Bariatric Surgery: Prevalence and Associated Risk Factors. Obes Surg. 2017 Nov; 27 (11):2905-2911
    View PubMed
24. Kumar A, Wermers RA, Tebben PJ. Iron replacement as a therapeutic approach for renal phosphate wasting with associated iron deficiency AACE Clinical Case Reports.2017;3:(3)e260-e263.
    
25. Singh Ospina N, Maraka S, Rodriguez-Gutierrez R, Espinosa de Ycaza AE, Jasim S, Gionfriddo M, Castaneda-Guarderas A, Brito JP, Al Nofal A, Erwin P, Wermers R, Montori V. Comparative efficacy of parathyroidectomy and active surveillance in patients with mild primary hyperparathyroidism: a systematic review and meta-analysis. Osteoporos Int. 2016 Dec; 27 (12):3395-3407 Epub 2016 Aug 25
    View PubMed
26. Sun PY, Thompson SM, Andrews JC, Wermers RA, McKenzie TJ, Richards ML, Farley DR, Thompson GB. Selective Parathyroid Hormone Venous Sampling in Patients with Persistent or Recurrent Primary Hyperparathyroidism and Negative, Equivocal or Discordant Noninvasive Imaging. World J Surg. 2016 Dec; 40 (12):2956-2963
    View PubMed
27. James HA, Wermers RA. "Petrified Ears": Auricular Ossification in Adrenal Insufficiency. Mayo Clin Proc. 2016 Oct; 91 (10):1487-1488
    View PubMed
28. O'Keeffe DT, Tebben PJ, Kumar R, Singh RJ, Wu Y, Wermers RA. Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect. Osteoporos Int. 2016 Oct; 27 (10):3121-5 Epub 2016 Apr 29
    View PubMed
29. Singh Ospina NM, Rodriguez-Gutierrez R, Maraka S, Espinosa de Ycaza AE, Jasim S, Castaneda-Guarderas A, Gionfriddo MR, Al Nofal A, Brito JP, Erwin P, Richards M, Wermers R, Montori VM. Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. World J Surg. 2016 Oct; 40 (10):2359-77
    View PubMed
30. Griebeler ML, Kearns AE, Ryu E, Thapa P, Hathcock MA, Melton LJ 3rd, Wermers RA. Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades. J Clin Endocrinol Metab. 2016 Mar; 101(3):1166-73. Epub 2016 Jan 11.
    View PubMed
31. Barajas MR, McCullough KB, Merten JA, Dierkhising RA, Bartoo GT, Hashmi SK, Hogan WJ, Litzow MR, Patnaik MM, Wilson JW, Wolf RC, Wermers RA. Correlation of Pain and Fluoride Concentration in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Voriconazole. Biol Blood Marrow Transplant. 2016 Mar; 22: (3)579-83.
    View PubMed
32. Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015 Apr; 73:1-7 Epub 2014 Dec 11
    View PubMed
33. LeBlanc A, Wang AT, Wyatt K, Branda ME, Shah ND, Van Houten H, Pencille L, Wermers R, Montori VM. Encounter Decision Aid vs. Clinical Decision Support or Usual Care to Support Patient-Centered Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial II. PLoS One. 2015; 10 (5):e0128063 Epub 2015 May 26
    View PubMed
34. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Self-report of hypoglycemia and health-related quality of life in patients with type 1 and type 2 diabetes. Endocr Pract. 2013 Sep-Oct; 19 (5):792-9
    View PubMed
35. Cosman F, Keaveny TM, Kopperdahl D, Wermers RA, Wan X, Krohn KD, Krege JH. Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene. J Bone Miner Res. 2013 Jun; 28(6):1328-36.
    View PubMed
36. Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA. Clinical spectrum of hypophosphatasia diagnosed in adults. Bone. 2013 May; 54(1):21-7. Epub 2013 Jan 22.
    View PubMed
37. Dhima M, Salinas TJ, Wermers RA, Weaver AL, Koka S. Preference changes of adult outpatients for giving saliva, urine and blood for clinical testing after actual sample collection. J Prosthodont Res. 2013 Jan; 57 (1):51-6 Epub 2013 Feb 01
    View PubMed
38. Dy BM, Grant CS, Wermers RA, Kearns AE, Huebner M, Harmsen WS, Thompson GB, Farley DR, Richards ML. Changes in bone mineral density after surgical intervention for primary hyperparathyroidism. Surgery. 2012 Dec; 152 (6):1051-8 Epub 2012 Oct 03
    View PubMed
39. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012 Sep; 35 (9):1897-901 Epub 2012 June 14
    View PubMed
40. Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA. Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1737-45. Epub 2011 Sep 14.
    View PubMed
41. Montori VM, Shah ND, Pencille LJ, Branda ME, Van Houten HK, Swiglo BA, Kesman RL, Tulledge-Scheitel SM, Jaeger TM, Johnson RE, Bartel GA, Melton LJ 3rd, Wermers RA. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med. 2011 Jun; 124 (6):549-56
    View PubMed
42. Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy. Clin Infect Dis. 2011 Mar 1; 52(5):604-11. Epub 2011 Jan 16.
    View PubMed
43. Pencille LJ, Campbell ME, Van Houten HK, Shah ND, Mullan RJ, Swiglo BA, Breslin M, Kesman RL, Tulledge-Scheitel SM, Jaeger TM, Johnson RE, Bartel GA, Wermers RA, Melton LJ 3rd, Montori VM. Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice. Trials. 2009 Dec 10; 10:113
    View PubMed
44. Cosman F, Wermers RA, Recknor C, Mauck KF, Xie L, Glass EV, Krege JH. Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent. J Clin Endocrinol Metab. 2009 Oct; 94(10):3772-80. Epub 2009 Jul 07.
    View PubMed
45. Khoo TK, Vege SS, Abu-Lebdeh HS, Ryu E, Nadeem S, Wermers RA. Acute pancreatitis in primary hyperparathyroidism: a population-based study. J Clin Endocrinol Metab. 2009 Jun; 94 (6):2115-8 Epub 2009 Mar 24
    View PubMed
46. Veldman MW, Reading CC, Farrell MA, Mullan BP, Wermers RA, Grant CS, Thompson GB. Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1. AJR Am J Roentgenol. 2008 Dec; 191(6):1740-4.
    View PubMed
47. Wermers RA, Recknor CP, Cosman F, Xie L, Glass EV, Krege JH. Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate. Osteoporos Int. 2008 Jul; 19 (7):1055-65 Epub 2008 Feb 19
    View PubMed
48. Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ 3rd. Morbidity and mortality associated with Paget's disease of bone: a population-based study. J Bone Miner Res. 2008 Jun; 23 (6):819-25
    View PubMed
49. Khoo TK, Baker CH, Abu-Lebdeh HS, Wermers RA. Suppressibility of parathyroid hormone in primary hyperparathyroidism. Endocr Pract. 2007 Nov-Dec; 13 (7):785-9
    View PubMed
50. Wermers RA, Kearns AE, Jenkins GD, Melton LJ 3rd. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med. 2007 Oct; 120 (10):911.e9-15 Epub 2007 Apr 16
    View PubMed
51. Hallanger Johnson JE, Kearns AE, Doran PM, Khoo TK, Wermers RA. Fluoride-related bone disease associated with habitual tea consumption. Mayo Clin Proc. 2007 Jun; 82 (6):719-24
    View PubMed
52. Karakelides H, Geller JL, Schroeter AL, Chen H, Behn PS, Adams JS, Hewison M, Wermers RA. Vitamin D-mediated hypercalcemia in slack skin disease: evidence for involvement of extrarenal 25-hydroxyvitamin D 1alpha-hydroxylase. J Bone Miner Res. 2006 Sep; 21 (9):1496-9
    View PubMed
53. Moayedoddin B, Booya F, Wermers RA, Lloyd RV, Rubin J, Thompson GB, Fatourechi V. Spectrum of malignant somatostatin-producing neuroendocrine tumors. Endocr Pract. 2006 Jul-Aug; 12(4):394-400.
    View PubMed
54. Chow LS, Erickson LA, Abu-Lebdeh HS, Wermers RA. Parathyroid lipoadenomas: a rare cause of primary hyperparathyroidism. Endocr Pract. 2006 Mar-Apr; 12 (2):131-6
    View PubMed
55. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ 3rd. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006 Jan; 21 (1):171-7 Epub 2005 Sept 19
    View PubMed
56. Wermers RA, Hurley DL, Kearns AE. Osteoporosis associated with megestrol acetate. Mayo Clin Proc. 2004 Dec; 79(12):1557-61.
    View PubMed
57. Erickson D, Huston J, Young WF, Carpenter PC, Wermers RA, Bonelli FS, Powell CC. Internal jugular vein sampling in adrenocorticotropic hormone-dependent Cushing's syndrome: a comparison with inferior petrosal sinus sampling. Clin Endocrinol (Oxf). 2004 Apr; 60: (4)413-9.
    View PubMed
58. Nora EH, Wermers RA. Visual vignette. Acute parathyroid crisis due to primary hyperparathyroidism. Endocr Pract. 2004 Jan-Feb; 10 (1):88
    View PubMed
59. Khosla S, Melton LJ 3rd, Wermers RA, Crowson CS, O'Fallon Wm, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res. 1999 Oct; 14 (10):1700-7
    View PubMed
60. Delaney SE, Wermers RA, Thompson GB, Hodgson SF, Dinneen SF. Mediastinal parathyroid carcinoma. Endocr Pract. 1999 May-Jun; 5 (3):133-6
    View PubMed
61. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM, Melton LJ 3rd, Melton LJ 3rd. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med. 1998 Feb; 104 (2):115-22
    View PubMed
62. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ 3rd, Melton LJ 3rd. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997 Mar 15; 126 (6):433-40
    View PubMed
63. Wermers RA, Fatourechi V, Kvols LK. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors. Mayo Clin Proc. 1996 Nov; 71 (11):1030-8
    View PubMed
64. Fatourechi V, Wermers RA. Glucagon-producing tumors and glucagonoma syndrome. Endocrinologist. 1996 Jul; 6(4):285-93.
    
65. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore). 1996 Mar; 75 (2):53-63
    View PubMed